Revolutionary drug for schizophrenia wins US approval
Elie Dolgin • September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
Read at Nature.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.